Patients with nonsquamous mNSCLC had higher cancer-directed treatment costs and total disease-related costs compared to those with squamous mNSCLC. Given the paucity of evidence comparing costs of squamous versus nonsquamous mNSCLC, this research should be reproduced in similar settings using other real-world data sources to evaluate the generalizability of these findings.
Article